WELL Health Technologies Corp.

WELL Health Technologies Corp.

2.58
USD
-0.11
(-4.14%)
-0.32EPS
819.89MMarket Cap
Mar 25Next Earn

Total Valuation

USD

As of September 30, 2026, Well Health Technologies Corp. carries a market capitalization of 819.89M, placing it among publicly traded companies globally. Its enterprise value stands at 1.48B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap819.89M
Enterprise Value1.48B

Important Dates

Well Health Technologies Corp.'s next confirmed earnings release is scheduled for March 25, 2027.

Earnings Date3/25/2027

Share Statistics

As of September 30, 2026, Well Health Technologies Corp. has 256.05M shares outstanding.

Shares Outstanding256.05M

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 0.74, and the price-to-book ratio stands at 1.46.

PS Ratio0.74
PB Ratio1.46
P/TBV Ratio-1.35
P/FCF Ratio15.84
P/OCF Ratio10.19

Enterprise Valuation

As of September 30, 2026, Well Health Technologies Corp. trades at an EV/EBITDA multiple of 19.48 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.35 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 802.24 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.48B versus a market cap of 819.89M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales1.35
EV / EBITDA19.48
EV / EBIT802.24

Financial Position

As of September 30, 2026, Well Health Technologies Corp. maintains a current ratio of 1.76, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 86.88, indicating elevated leverage, while an interest coverage ratio of 1.05 demonstrates limited ability to service its debt obligations.

Current Ratio1.76
Quick Ratio1.59
Debt / Equity86.88
Debt / EBITDA8.40
Interest Coverage1.05

Financial Efficiency

USD

These figures cover the twelve months ended September 30, 2026. The company generates approximately 342,813.49 in revenue per employee across its workforce of 3,200.00, a quick read on workforce productivity versus industry peers.

Revenue Per Employee342,813.49
Employee Count3,200.00

Taxes

USD

Over the twelve months ended September 30, 2026, Well Health Technologies Corp. recorded an income tax benefit of -2.55M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -84.51M and -90.50M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax-2.55M

Stock Price Statistics

USD

As of the close on November 16, 2026, Well Health Technologies Corp.'s stock has declined approximately 10.88% over the past 52 weeks. The 50-day moving average sits at 2.98, while the 200-day moving average is 3.01.

52-Week Price Change-10.88%
50-Day Moving Average2.98
200-Day Moving Average3.01

Income Statement

USD

Over the twelve months ended September 30, 2026, Well Health Technologies Corp. generated 1.10B in revenue and converted that into -90.50M in net income, yielding earnings per share of -0.32. EBITDA reached 76.23M, while operating income came in at 51.03M.

Revenue1.10B
Gross Profit489.37M
Operating Income51.03M
Pretax Income-84.51M
Net Income-90.50M
EBITDA76.23M
EBIT1.85M
Earnings Per Share (EPS)-0.32

Balance Sheet

USD

As of September 30, 2026, Well Health Technologies Corp. holds 152.27M in cash and equivalents against 640.42M in total debt, resulting in a net debt position of 422.02M. Total book value stands at 560.60M, with working capital of 146.57M providing operational flexibility.

Cash & Cash Equivalents152.27M
Total Debt640.42M
Net Debt422.02M
Equity (Book Value)560.60M
Book Value Per Share2.19
Working Capital146.57M

Cash Flow

USD

Well Health Technologies Corp. produced 80.18M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -28.61M in capital expenditures, free cash flow totaled 51.57M - equivalent to 0.20 per share.

Operating Cash Flow80.18M
Capital Expenditures-28.61M
Free Cash Flow51.57M
FCF Per Share0.20

Margins

Over the twelve months ended September 30, 2026, Well Health Technologies Corp. posted a gross margin of 44.61, reflecting its pricing power and cost economics. The operating margin of 4.65 and net profit margin of -8.25 provide insight into operational efficiency.

Gross Margin44.61
Operating Margin4.65
Pretax Margin-7.70
Profit Margin-8.25
EBITDA Margin6.95

Dividends & Yields

Over the twelve months ended September 30, 2026, Well Health Technologies Corp. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 6.31, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -19.52, meaning Well Health Technologies Corp. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-19.52
FCF Yield6.31

Scores

As of September 30, 2026, Well Health Technologies Corp. has an Altman Z-Score of 3.25, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.25